0000921895-20-003084.txt : 20201120
0000921895-20-003084.hdr.sgml : 20201120
20201120194610
ACCESSION NUMBER: 0000921895-20-003084
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201118
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Valentino Michael J
CENTRAL INDEX KEY: 0001319551
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36351
FILM NUMBER: 201333958
MAIL ADDRESS:
STREET 1: 8285 EL RIO STREET
STREET 2: SUITE 130
CITY: HOUSTON
STATE: TX
ZIP: 77054
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PLx Pharma Inc.
CENTRAL INDEX KEY: 0001497504
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 271707962
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
BUSINESS PHONE: (713) 842-1249
MAIL ADDRESS:
STREET 1: 9 FISHERS LANE
STREET 2: SUITE E
CITY: SPARTA
STATE: NJ
ZIP: 07871
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20140313
FORMER COMPANY:
FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20100726
4
1
form411577002val_11202020.xml
OWNERSHIP DOCUMENT
X0306
4
2020-11-18
0
0001497504
PLx Pharma Inc.
PLXP
0001319551
Valentino Michael J
9 FISHERS LANE
SUITE E
SPARTA
NJ
07871
1
1
0
0
Executive Chairman
Common Stock
2020-11-18
4
P
0
264900
3.787
A
461690
D
Stock Option (right to buy)
5.15
2020-11-18
4
A
0
160000
0
A
2030-11-18
Common Stock
160000
160000
D
Warrants (right to buy)
4.31
2020-11-18
4
P
0
291390
A
2020-11-18
2025-11-18
Common Stock
291390
291390
D
Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan.
These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date.
Issued pursuant to a private placement in connection with the purchase of immediately serparable units comprised of common stock and warrants.
/s/ Natasha Giordano, as Attorney-in-Fact
2020-11-20